AUSTRALIAN CLINICAL LABS LIMITED - Announcements

0.54%

$2.79

Market Cap $545.9M

Healthcare Medical Care

Australian Clinical Labs Limited is a private provider of pathology services. Its... Australian Clinical Labs Limited is a private provider of pathology services. Its laboratories perform a range of pathology tests each year for a range of clients, including doctors, specialists, patients, hospitals, and corporate clients. It performs a range of services for doctors, patients and corporate clients, including chemical pathology, hematology, histopathology & cytopathology, serology & microbiology, allergy & immunology, molecular cancer testing, genetic carrier screening & other antenatal testing, cardiac testing services, veterinary pathology, functional pathology, and pathology services for clinical trials, among others. Its specialist services include molecular cancer services, obstetrics and gynecology, pharmacogenetic testing, gastroenterology, and hospital services. It has operations in Victoria, New South Wales, Western Australia, South Australia, Queensland, and the Northern Territory. Its SunDoctors brand provides skin cancer care services.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

ACL	Response to ASX Aware Letter	PRICE SENSITIVE	28/02/25	332.67KB	Share
ACL	1H25 financial results investor presentation	PRICE SENSITIVE	26/02/25	2.21MB	Share
ACL	Appendix 4D and 1H25 financial statements	PRICE SENSITIVE	26/02/25	627.51KB	Share
ACL	Sale of Crescent Capital shareholding	PRICE SENSITIVE	12/09/24	119.2KB	Share
ACL	Notification of buy-back - ACL	PRICE SENSITIVE	29/08/24	13.14KB	Share
ACL	FY24 financial results investor presentation	PRICE SENSITIVE	29/08/24	1.85MB	Share
ACL	Appendix 4E and FY24 financial statements	PRICE SENSITIVE	29/08/24	6.63MB	Share
ACL	FY24 Trading Update	PRICE SENSITIVE	21/05/24	114.17KB	Share
ACL	1H24 investor presentation	PRICE SENSITIVE	28/02/24	895.03KB	Share
ACL	Appendix 4D and 1H24 financial reports	PRICE SENSITIVE	28/02/24	561.02KB	Share
ACL	Notice of withdrawal of offer - Healius Limited	PRICE SENSITIVE	22/12/23	321.02KB	Share
ACL	HLS:ACCC Rejection&ACL Notice of Intention to Withdraw Offer	PRICE SENSITIVE	15/12/23	123.24KB	Share
ACL	Intention to withdraw takeover offer for Healius	PRICE SENSITIVE	15/12/23	380.57KB	Share
ACL	AXX:Accc opposes Australian Clinical Labs' proposed acquis	PRICE SENSITIVE	15/12/23	128.55KB	Share
ACL	Takeover offer - Healius entitlement offer	PRICE SENSITIVE	21/11/23	150.34KB	Share
ACL	Fourth Supplementary Bidder's Statement	PRICE SENSITIVE	09/11/23	512.79KB	Share
ACL	Extension of offer period - notice of variation	PRICE SENSITIVE	01/11/23	277.5KB	Share
ACL	Takeover offer for Healius - extension of offer period	PRICE SENSITIVE	01/11/23	158.04KB	Share
ACL	Notice of fulfilment of conditions	PRICE SENSITIVE	09/10/23	217.8KB	Share
ACL	Third Supplementary Bidder's Statement	PRICE SENSITIVE	09/10/23	259.13KB	Share
ACL	HLS: Supplementary Target's Statement	PRICE SENSITIVE	05/09/23	707.84KB	Share
ACL	FY23 investor results presentation	PRICE SENSITIVE	22/08/23	1.6MB	Share
ACL	Appendix 4E and FY23 financial reports	PRICE SENSITIVE	22/08/23	2.97MB	Share
ACL	HLS: ACCC Statement of Issues	PRICE SENSITIVE	20/07/23	138.1KB	Share
ACL	Takeover bid for Healius Limited - extension of offer period	PRICE SENSITIVE	20/07/23	246.68KB	Share
ACL	AXX: ACL's proposed acquisition of Healius raises concerns	PRICE SENSITIVE	20/07/23	204.97KB	Share
ACL	HLS: Directors' Statement re Takeover	PRICE SENSITIVE	23/05/23	142.59KB	Share
ACL	Response to Healius' Target's Statement	PRICE SENSITIVE	22/05/23	176.33KB	Share
ACL	Second Supplementary Bidder's Statement	PRICE SENSITIVE	22/05/23	3.05MB	Share
ACL	HLS: Lodgement of Target's Statement	PRICE SENSITIVE	04/05/23	1.1MB	Share
ACL	TOV: HLS Panel Declines to Conduct Proceedings	PRICE SENSITIVE	17/04/23	93.48KB	Share
ACL	ASX announcement - Replacement Bidder's Statement	PRICE SENSITIVE	14/04/23	208.73KB	Share
ACL	Replacement Bidder's Statement	PRICE SENSITIVE	14/04/23	6.11MB	Share
ACL	First Supplementary Bidder's Statement	PRICE SENSITIVE	14/04/23	6.36MB	Share
ACL	TOV: HLS Panel Receives Application	PRICE SENSITIVE	29/03/23	114.08KB	Share
ACL	HLS: Directors' Statement re Takeover	PRICE SENSITIVE	27/03/23	171.75KB	Share
ACL	HLS: Off-market takeover bid from ACL	PRICE SENSITIVE	20/03/23	84.53KB	Share
ACL	Investor Webinar - Takeover Offer for Healius	PRICE SENSITIVE	20/03/23	129.09KB	Share
ACL	Investor Presentation - Takeover Offer for Healius	PRICE SENSITIVE	20/03/23	1.14MB	Share
ACL	Bidder's Statement in relation to Takeover Offer for Healius	PRICE SENSITIVE	20/03/23	5.25MB	Share
ACL	Takeover Offer for Healius Limited	PRICE SENSITIVE	20/03/23	364.62KB	Share
ACL	1H23 results investor presentation	PRICE SENSITIVE	20/02/23	1.57MB	Share
ACL	Appendix 4D and 1H23 financial reports	PRICE SENSITIVE	20/02/23	790.04KB	Share
ACL	2022 AGM - addresses to shareholders	PRICE SENSITIVE	19/10/22	1MB	Share
ACL	S&P DJI Announces September 2022 Quarterly Rebalance	PRICE SENSITIVE	02/09/22	134KB	Share
ACL	Second letter from Crescent Capital	PRICE SENSITIVE	12/08/22	405.53KB	Share
ACL	Letter received from Crescent Capital	PRICE SENSITIVE	12/08/22	513.69KB	Share
ACL	FY22 Investor Presentation	PRICE SENSITIVE	10/08/22	1.29MB	Share
ACL	Appendix 4E - Preliminary Financial Report	PRICE SENSITIVE	10/08/22	159.04KB	Share
ACL	Response to Market Enquiries	PRICE SENSITIVE	06/06/22	224.48KB	Share
ACL	S&P DJI Announces March 2022 Quarterly Rebalance	PRICE SENSITIVE	04/03/22	175.5KB	Share
ACL	Establishment of Dividend Reinvestment Plan	PRICE SENSITIVE	24/02/22	1.16MB	Share
ACL	1H22 Investor Presentation	PRICE SENSITIVE	24/02/22	1.8MB	Share
ACL	Media Release - 1H22 Financial Results	PRICE SENSITIVE	24/02/22	863.48KB	Share
ACL	Appendix 4D	PRICE SENSITIVE	24/02/22	35.23KB	Share
ACL	Letter from Crescent Capital Partners	PRICE SENSITIVE	21/12/21	233.11KB	Share
ACL	Upgrade to 1H FY22 Pro Forma Expectations	PRICE SENSITIVE	21/12/21	384.7KB	Share
ACL	Completion of Medlab Acquisition	PRICE SENSITIVE	20/12/21	345.94KB	Share
ACL	Medlab Pathology - Investor Presentation	PRICE SENSITIVE	15/11/21	1.38MB	Share
ACL	Acquisition of Medlab Pathology by ACL	PRICE SENSITIVE	15/11/21	366.18KB	Share
ACL	2021 AGM addresses and 1H22 trading update	PRICE SENSITIVE	27/10/21	1.27MB	Share
ACL	1H FY22 Updated Profit Guidance	PRICE SENSITIVE	28/09/21	336.95KB	Share
ACL	FY21 financial results investor presentation	PRICE SENSITIVE	26/08/21	2.39MB	Share
ACL	Preliminary Final Report	PRICE SENSITIVE	26/08/21	372.33KB	Share
ACL	Upgraded FY21 earnings guidance by 10 to 15%	PRICE SENSITIVE	03/06/21	358.88KB	Share

ACL Response to ASX Aware Letter
28/02/25	PRICE SENSITIVE	332.67KB	Share
ACL 1H25 financial results investor presentation
26/02/25	PRICE SENSITIVE	2.21MB	Share
ACL Appendix 4D and 1H25 financial statements
26/02/25	PRICE SENSITIVE	627.51KB	Share
ACL Sale of Crescent Capital shareholding
12/09/24	PRICE SENSITIVE	119.2KB	Share
ACL Notification of buy-back - ACL
29/08/24	PRICE SENSITIVE	13.14KB	Share
ACL FY24 financial results investor presentation
29/08/24	PRICE SENSITIVE	1.85MB	Share
ACL Appendix 4E and FY24 financial statements
29/08/24	PRICE SENSITIVE	6.63MB	Share
ACL FY24 Trading Update
21/05/24	PRICE SENSITIVE	114.17KB	Share
ACL 1H24 investor presentation
28/02/24	PRICE SENSITIVE	895.03KB	Share
ACL Appendix 4D and 1H24 financial reports
28/02/24	PRICE SENSITIVE	561.02KB	Share
ACL Notice of withdrawal of offer - Healius Limited
22/12/23	PRICE SENSITIVE	321.02KB	Share
ACL HLS:ACCC Rejection&ACL Notice of Intention to Withdraw Offer
15/12/23	PRICE SENSITIVE	123.24KB	Share
ACL Intention to withdraw takeover offer for Healius
15/12/23	PRICE SENSITIVE	380.57KB	Share
ACL AXX:Accc opposes Australian Clinical Labs' proposed acquis
15/12/23	PRICE SENSITIVE	128.55KB	Share
ACL Takeover offer - Healius entitlement offer
21/11/23	PRICE SENSITIVE	150.34KB	Share
ACL Fourth Supplementary Bidder's Statement
09/11/23	PRICE SENSITIVE	512.79KB	Share
ACL Extension of offer period - notice of variation
01/11/23	PRICE SENSITIVE	277.5KB	Share
ACL Takeover offer for Healius - extension of offer period
01/11/23	PRICE SENSITIVE	158.04KB	Share
ACL Notice of fulfilment of conditions
09/10/23	PRICE SENSITIVE	217.8KB	Share
ACL Third Supplementary Bidder's Statement
09/10/23	PRICE SENSITIVE	259.13KB	Share
ACL HLS: Supplementary Target's Statement
05/09/23	PRICE SENSITIVE	707.84KB	Share
ACL FY23 investor results presentation
22/08/23	PRICE SENSITIVE	1.6MB	Share
ACL Appendix 4E and FY23 financial reports
22/08/23	PRICE SENSITIVE	2.97MB	Share
ACL HLS: ACCC Statement of Issues
20/07/23	PRICE SENSITIVE	138.1KB	Share
ACL Takeover bid for Healius Limited - extension of offer period
20/07/23	PRICE SENSITIVE	246.68KB	Share
ACL AXX: ACL's proposed acquisition of Healius raises concerns
20/07/23	PRICE SENSITIVE	204.97KB	Share
ACL HLS: Directors' Statement re Takeover
23/05/23	PRICE SENSITIVE	142.59KB	Share
ACL Response to Healius' Target's Statement
22/05/23	PRICE SENSITIVE	176.33KB	Share
ACL Second Supplementary Bidder's Statement
22/05/23	PRICE SENSITIVE	3.05MB	Share
ACL HLS: Lodgement of Target's Statement
04/05/23	PRICE SENSITIVE	1.1MB	Share
ACL TOV: HLS Panel Declines to Conduct Proceedings
17/04/23	PRICE SENSITIVE	93.48KB	Share
ACL ASX announcement - Replacement Bidder's Statement
14/04/23	PRICE SENSITIVE	208.73KB	Share
ACL Replacement Bidder's Statement
14/04/23	PRICE SENSITIVE	6.11MB	Share
ACL First Supplementary Bidder's Statement
14/04/23	PRICE SENSITIVE	6.36MB	Share
ACL TOV: HLS Panel Receives Application
29/03/23	PRICE SENSITIVE	114.08KB	Share
ACL HLS: Directors' Statement re Takeover
27/03/23	PRICE SENSITIVE	171.75KB	Share
ACL HLS: Off-market takeover bid from ACL
20/03/23	PRICE SENSITIVE	84.53KB	Share
ACL Investor Webinar - Takeover Offer for Healius
20/03/23	PRICE SENSITIVE	129.09KB	Share
ACL Investor Presentation - Takeover Offer for Healius
20/03/23	PRICE SENSITIVE	1.14MB	Share
ACL Bidder's Statement in relation to Takeover Offer for Healius
20/03/23	PRICE SENSITIVE	5.25MB	Share
ACL Takeover Offer for Healius Limited
20/03/23	PRICE SENSITIVE	364.62KB	Share
ACL 1H23 results investor presentation
20/02/23	PRICE SENSITIVE	1.57MB	Share
ACL Appendix 4D and 1H23 financial reports
20/02/23	PRICE SENSITIVE	790.04KB	Share
ACL 2022 AGM - addresses to shareholders
19/10/22	PRICE SENSITIVE	1MB	Share
ACL S&P DJI Announces September 2022 Quarterly Rebalance
02/09/22	PRICE SENSITIVE	134KB	Share
ACL Second letter from Crescent Capital
12/08/22	PRICE SENSITIVE	405.53KB	Share
ACL Letter received from Crescent Capital
12/08/22	PRICE SENSITIVE	513.69KB	Share
ACL FY22 Investor Presentation
10/08/22	PRICE SENSITIVE	1.29MB	Share
ACL Appendix 4E - Preliminary Financial Report
10/08/22	PRICE SENSITIVE	159.04KB	Share
ACL Response to Market Enquiries
06/06/22	PRICE SENSITIVE	224.48KB	Share
ACL S&P DJI Announces March 2022 Quarterly Rebalance
04/03/22	PRICE SENSITIVE	175.5KB	Share
ACL Establishment of Dividend Reinvestment Plan
24/02/22	PRICE SENSITIVE	1.16MB	Share
ACL 1H22 Investor Presentation
24/02/22	PRICE SENSITIVE	1.8MB	Share
ACL Media Release - 1H22 Financial Results
24/02/22	PRICE SENSITIVE	863.48KB	Share
ACL Appendix 4D
24/02/22	PRICE SENSITIVE	35.23KB	Share
ACL Letter from Crescent Capital Partners
21/12/21	PRICE SENSITIVE	233.11KB	Share
ACL Upgrade to 1H FY22 Pro Forma Expectations
21/12/21	PRICE SENSITIVE	384.7KB	Share
ACL Completion of Medlab Acquisition
20/12/21	PRICE SENSITIVE	345.94KB	Share
ACL Medlab Pathology - Investor Presentation
15/11/21	PRICE SENSITIVE	1.38MB	Share
ACL Acquisition of Medlab Pathology by ACL
15/11/21	PRICE SENSITIVE	366.18KB	Share
ACL 2021 AGM addresses and 1H22 trading update
27/10/21	PRICE SENSITIVE	1.27MB	Share
ACL 1H FY22 Updated Profit Guidance
28/09/21	PRICE SENSITIVE	336.95KB	Share
ACL FY21 financial results investor presentation
26/08/21	PRICE SENSITIVE	2.39MB	Share
ACL Preliminary Final Report
26/08/21	PRICE SENSITIVE	372.33KB	Share
ACL Upgraded FY21 earnings guidance by 10 to 15%
03/06/21	PRICE SENSITIVE	358.88KB	Share

REFRESH

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $2.79		Change -0.015(0.54%)		Mkt cap ! $545.9M

Open	High	Low	Value	Volume
$2.79	$2.80	$2.78	$394.0K	141.6K

Buyers (Bids)

No.	Vol.	Price($)
11	20350	$2.78

Sellers (Offers)

Price($)	Vol.	No.
$2.79	9000	23

View Market Depth

No.	Vol.	Price($)
11	20350	2.780
11	41128	2.770
11	37311	2.760
15	35155	2.750
9	23138	2.740

Price($)	Vol.	No.
2.790	9244	23
2.800	14973	14
2.810	2822	3
2.820	33812	9
2.830	10685	5

Last trade - 11.09am 31/07/2025 (20 minute delay)


Last $2.78		Change -0.015 ( 0.86 %)
Open	High	Low	Volume
$2.78	$2.80	$2.77	16076
Last updated 11.24am 31/07/2025 ?

ACL (ASX) Chart

AUSTRALIAN CLINICAL LABS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available